Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2021 - Volume 25, Number 2
View All Articles in Issue

Page(s):  145

Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $75

Abstract:  A formulation for preparing Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, levodopa, carbidopa, parkinsonian syndrome, parkinsonism, decarboxylase inhibitor, stability

Related Categories: EXCIPIENTS, FORMULATIONS, DOSAGE FORMS/DRUG CARRIERS, MUSCULOSKELETAL DISORDERS, NEUROLOGY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2021
Pg. 145

Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
Mar/Apr 2018
Pg. 149

Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Allen Loyd V Jr
May/Jun 2002
Pg. 202

Carbidopa 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
Jan/Feb 2007
Pg. 70

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Basics of Compounding for Cough
Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465

Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Nov/Dec 2018
Pg. 494

Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 318

Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2019
Pg. 491

Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Mar/Apr 2020
Pg. 138

Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2020
Pg. 224

Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2018
Pg. 233

Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Jul/Aug 2020
Pg. 315

Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 421

Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
May/Jun 2019
Pg. 234

Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Nov/Dec 2021
Pg. 508

Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417

Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B
, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jul/Aug 2020
Pg. 327-336

Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Jan/Feb 2020
Pg. 55

Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2019
Pg. 408

Return to Top